Analysis of prognostic factors and applicability of Kohne's prognostic groups in patients with metastatic colorectal cancer treated with first-line irinotecan or oxaliplatin-based chemotherapy. [electronic resource]
- Clinical colorectal cancer Sep 2005
- 197-202 p. digital
Publication Type: Journal Article
1533-0028
10.3816/ccc.2005.n.031 doi
Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols--therapeutic use Biomarkers, Tumor--analysis Camptothecin--administration & dosage Colorectal Neoplasms--drug therapy Female Humans Irinotecan Male Middle Aged Neoplasm Metastasis Organoplatinum Compounds--administration & dosage Oxaliplatin Predictive Value of Tests Prognosis Retrospective Studies Treatment Outcome